0001513160-11-000056.txt : 20110901
0001513160-11-000056.hdr.sgml : 20110901
20110901190025
ACCESSION NUMBER: 0001513160-11-000056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110831
FILED AS OF DATE: 20110901
DATE AS OF CHANGE: 20110901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Saloff David
CENTRAL INDEX KEY: 0001375530
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 111072001
MAIL ADDRESS:
STREET 1: C/O GMID
STREET 2: 12100 WILSHIRE BLVD., SUITE 800
CITY: LOS ANGELES
STATE: CA
ZIP: 90025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OXIS INTERNATIONAL INC
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 468 N. CAMDEN DR.
STREET 2: 2ND FLOOR
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90210
BUSINESS PHONE: (310) 551-4020
MAIL ADDRESS:
STREET 1: 468 N. CAMDEN DR.
STREET 2: 2ND FLOOR
CITY: BEVERLY HILLS
STATE: CA
ZIP: 90210
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0304
4
2011-08-31
0
0000109657
OXIS INTERNATIONAL INC
OXIS.OB
0001375530
Saloff David
1
1
0
0
Chief Executive Officer
Common Stock Option
0.0535
2011-08-31
4
A
0
538713
0.0535
A
2021-08-31
Common Stock
538713
1316491
D
David Saloff received a non-qualified stock option to purchase 538,713 shares of Common Stock under the Issuer's 2010 Equity Incentive Plan, in connection with his appointment as Chief Executive Officer of the Company. The options vest and become exercisable in equal quarterly installments during the one-year period following the date of grant. The options have a term of 10 years from the date of grant.
/s/ David Saloff
2011-09-01